Research desk · PCRX · Nasdaq
PCRX Stock
SEC financials, peer compare, and chart. Scores open the matching desk. Research only — not advice.
PACIRA BIOSCIENCES, INC. · Pharmaceutical Preparations
PACIRA BIOSCIENCES, INC. financial statements, chart, and peer compare from SEC filings.
PACIRA BIOSCIENCES, INC. (PCRX) discovers, develops, or markets pharmaceutical products.
- Market cap
- $989.93M
- P/E
- 34.53
- Op. margin
- 6.29%
- Profit margin
- 4.38%
- FCF margin
- 14.42%
- ROE
- 4.75%
Related Health Care stocks: ACAD stock financials · RGEN stock financials · HRMY stock financials · ALKS stock financials · TGTX stock financials
PCRX financial statements
Each Compare name is its own block of years. Filing lines are SEC reports; P/E and price sit on that name’s TTM column only.
PCRX stock peer compare
Each bar is that name’s percent vs its last TTM, on one zero line. Zero is unchanged. This ticker is the black bar.
Focus chart
Zero is unchanged vs last TTM. Every name is a percent for the metric you pick.
PCRX stock peer headlines
Yahoo Finance RSS for PCRX and the names in Compare.
| Ticker | Date | Headline |
|---|---|---|
| Loading headlines… | ||
PCRX stock price chart
Overlays follow the Compare table.
PCRX stock — research snapshot
Screen strengths and watchouts for PCRX stock from the latest Misprise snapshot.
Strengths
- FCF margin 14.4% — cash conversion looks healthy.
- Revenue CAGR 5Y 11.1% — durable top-line compound.
- Debt/equity 0.54 — leverage looks manageable.
- Current ratio 5.04 — liquidity cushion.
Watchouts
- ROA 2.6% — muted asset returns.
- ROE 4.8% — soft equity returns.
- EPS CAGR negative — earnings trajectory is soft.
- Recent EPS growth -47.8% — earnings momentum is weak.
- Rev CAGR 5Y 11.1%
- Rev CAGR 3Y 2.9%
- EPS CAGR 5Y -45.7%
- EPS CAGR 3Y -23.0%
- FCF CAGR 5Y 28.4%
- FCF CAGR 3Y 5.9%
PCRX stock FAQs
Short answers for PCRX stock — statements, sector, and how this page is meant to be used.
What is PCRX stock?
PACIRA BIOSCIENCES, INC. (PCRX) discovers, develops, or markets pharmaceutical products. PCRX stock sits in Health Care (Pharmaceutical Preparations), listed on Nasdaq.
Where can I find PACIRA BIOSCIENCES, INC. financial statements?
PACIRA BIOSCIENCES, INC. financial statements — income statement, balance sheet, and cash flow — are on this PCRX stock page, parsed from SEC 10-K and 10-Q filings. Use Annual or Quarterly, then the statement tabs. Research only.
What happened to PCRX stock?
This page is a research snapshot of PACIRA BIOSCIENCES, INC. (PCRX) from the latest SEC filings in the Misprise database as of TTM. It is not a news feed or a delisting notice. Open the financial statements, chart, and peer compare below, then read the filings. Research only — not financial advice.
Does this page show the PCRX stock price?
The live chart on this PCRX stock page is the same TradingView chart as the screener. Statement tables use SEC filings. Any price or multiple on the TTM column is a market snapshot from the last seed, not a real-time quote. Research only.
What sector is PCRX stock in?
PACIRA BIOSCIENCES, INC. is classified in Pharmaceutical Preparations, inside the Health Care sector, and trades on Nasdaq. This page is a research snapshot, not a full company profile.
How do I read PCRX financial statements?
Start with this ticker’s block (TTM, then its fiscal years or quarters). Each Compare name is a separate block of its own periods — not mixed by year. A blank is a period we do not have, not a zero. Research only — not a buy or sell.
Where does the PCRX statement data come from?
Income, balance sheet, and cash-flow lines are parsed from SEC company filings (10-K / 10-Q and 20-F). TTM is the last four reported quarters added together, not a separate filing. P/E, forward P/E, price, and market cap are a market quote at last seed — trailing P/E from the quote when available, otherwise last price divided by TTM EPS. They are not 10-K line items and appear on the TTM column only. Research only — not financial advice.
Where can I find the PCRX income statement, balance sheet, and cash flow?
On this PCRX stock page, open Financial statements and use the Income, Balance sheet, and Cash flow tabs. Growth and valuation sit under More. Filing figures are from SEC reports; valuation multiples are the market snapshot described above.
What is the Misprise Score for PCRX stock?
PCRX stock currently scores 17/100 (Watch / incomplete (<60)). PACIRA BIOSCIENCES, INC. scores weaker or incomplete on durable growth/quality inputs — leverage, coverage, and recent results deserve extra scrutiny. The score is a screen of quality, growth, and balance-sheet inputs — not a price target. Compare it in the Misprise screener; it is not a separate score page.
How is the PCRX comparison winner decided?
Lead and Tie follow the number printed on each factor row, not a blended category score. Growth, quality, score, current ratio, and coverage: the higher figure leads. Value multiples (P/E, PEG, P/B, P/S) and debt ratios: the lower figure leads. Tie appears only when those printed numbers match. The header winner is whoever takes more of those five rows. CAGR uses the 5-year horizon and drops to 3-year only when both names report it. Research only — not a buy or sell.
What is the Anomaly Score on this PCRX page?
Anomaly Score is how unusual a filing pattern is versus this company’s own history and its industry — not the same as Misprise Score. A high anomaly with a weak Misprise Score is often a noisy name. Open the anomaly detector to see the flag. Research only — not financial advice.
What does the green grant dot mean on PCRX stock?
A green circle next to the title means this ticker appears in the Misprise grants calendar with a recent federal award (USASpending / SAM). Tap the dot for date, agency, and amount when available. It is a research flag only — not a buy or sell signal.
Is PCRX stock a buy?
No recommendation either way. This PCRX stock page organizes statements, ratios, and peers so you can do your own work. It is educational only — not advice to buy or sell PACIRA BIOSCIENCES, INC..